Linda C. Duffy PhD, MPH

Linda Duffy, Ph.D., M.P.H., administers the translational and clinical projects portfolio for probiotics and microbiota microbiome studies under regulatory Investigational New Drugs. Particular programmatic focus has been on evidence-based safety and efficacy for specific Lactobacillus and Bifidobacterium strains, including building validation standards using innovative molecular technologies and modeling tools that can fill methodological gaps in science and inform regulatory policy. Her portfolio also encompasses translational and clinical projects for a range of natural products and mindfulness modalities, particularly in pediatrics, obesity, metabolic disorders, and microbial ecology computational models.